Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $41.3000 (-1.78%) ($41.1300 - $41.3000) on Thu. Sep. 9, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.95% (three month average) | RSI | 69 | Latest Price | $41.3000(-1.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.3% a day on average for past five trading days. | Weekly Trend | HALO advances 2.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(49%) IWM(48%) IWC(44%) IWN(44%) | Factors Impacting HALO price | HALO will decline at least -0.975% in a week (0% probabilities). VIXM(-28%) VXX(-10%) UUP(-10%) IGOV(-5%) GLD(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.975% (StdDev 1.95%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $42.26(-2.27%) | 10 Day Moving Average | $41.96(-1.57%) | 20 Day Moving Average | $41.23(0.17%) | To recent high | -11% | To recent low | 7.8% | Market Cap | $5.645b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |